Samples for study ST001024
Species: Homo sapiens (Factor headings shown in green)
| mb_sample_id | Subject name | Sample name | Sample type | Sample_Data:Species | Volume |
|---|---|---|---|---|---|
| SA064320 | - | Sample # 1 | Cells | Grouping:IV Control | Human | 3-5 millions |
| SA064321 | - | Sample # 2 | Cells | Grouping:IV Control | Human | 3-5 millions |
| SA064322 | - | Sample # 3 | Cells | Grouping:IV Control | Human | 3-5 millions |
| SA064323 | - | Sample # 7 | Cells | Grouping:IV Treatment 1 | Human | 3-5 millions |
| SA064324 | - | Sample # 8 | Cells | Grouping:IV Treatment 1 | Human | 3-5 millions |
| SA064325 | - | Sample # 9 | Cells | Grouping:IV Treatment 1 | Human | 3-5 millions |
| SA064328 | - | Sample # 13 | Cells | Grouping:IV Treatment 2 | Human | 3-5 millions |
| SA064326 | - | Sample # 14 | Cells | Grouping:IV Treatment 2 | Human | 3-5 millions |
| SA064327 | - | Sample # 15 | Cells | Grouping:IV Treatment 2 | Human | 3-5 millions |
| SA064331 | - | Sample # 19 | Cells | Grouping:XVII Control | Human | 3-5 millions |
| SA064329 | - | Sample # 20 | Cells | Grouping:XVII Control | Human | 3-5 millions |
| SA064330 | - | Sample # 21 | Cells | Grouping:XVII Control | Human | 3-5 millions |
| SA064334 | - | Sample # 25 | Cells | Grouping:XVII Treatment 1 | Human | 3-5 millions |
| SA064333 | - | Sample # 26 | Cells | Grouping:XVII Treatment 1 | Human | 3-5 millions |
| SA064332 | - | Sample # 27 | Cells | Grouping:XVII Treatment 1 | Human | 3-5 millions |
| SA064337 | - | Sample # 31 | Cells | Grouping:XVII Treatment 2 | Human | 3-5 millions x2 vials |
| SA064335 | - | Sample # 32 | Cells | Grouping:XVII Treatment 2 | Human | 3-5 millions x2 vials |
| SA064336 | - | Sample # 33 | Cells | Grouping:XVII Treatment 2 | Human | 3-5 millions x2 vials |
| SA064340 | - | Sample # 4 | Media | Grouping:IV Control | Human | 1 mL |
| SA064338 | - | Sample # 5 | Media | Grouping:IV Control | Human | 1 mL |
| SA064339 | - | Sample # 6 | Media | Grouping:IV Control | Human | 1 mL |
| SA064343 | - | Sample # 10 | Media | Grouping:IV Treatment 1 | Human | 1 mL |
| SA064342 | - | Sample # 11 | Media | Grouping:IV Treatment 1 | Human | 1 mL |
| SA064341 | - | Sample # 12 | Media | Grouping:IV Treatment 1 | Human | 1 mL |
| SA064346 | - | Sample # 16 | Media | Grouping:IV Treatment 2 | Human | 1 mL |
| SA064345 | - | Sample # 17 | Media | Grouping:IV Treatment 2 | Human | 1 mL |
| SA064344 | - | Sample # 18 | Media | Grouping:IV Treatment 2 | Human | 1 mL |
| SA064347 | - | Sample # 22 | Media | Grouping:XVII Control | Human | 1 mL |
| SA064349 | - | Sample # 23 | Media | Grouping:XVII Control | Human | 1 mL |
| SA064348 | - | Sample # 24 | Media | Grouping:XVII Control | Human | 1 mL |
| SA064350 | - | Sample # 28 | Media | Grouping:XVII Treatment 1 | Human | 1 mL |
| SA064352 | - | Sample # 29 | Media | Grouping:XVII Treatment 1 | Human | 1 mL |
| SA064351 | - | Sample # 30 | Media | Grouping:XVII Treatment 1 | Human | 1 mL |
| SA064354 | - | Sample # 34 | Media | Grouping:XVII Treatment 2 | Human | 1 mL x2 vials |
| SA064355 | - | Sample # 35 | Media | Grouping:XVII Treatment 2 | Human | 1 mL x2 vials |
| SA064353 | - | Sample # 36 | Media | Grouping:XVII Treatment 2 | Human | 1 mL x2 vials |
